Matthew Kiernan


Matthew Kiernan

1999 NHMRC Menzies Fellow

Scholarship biography (at time of award)

Matthew Kiernan graduated with a Bachelor of Medicine and Bachelor of Surgery with Honours from the University of Sydney in 1990. After graduating he completed his clinical training at the Royal Prince Alfred Hospital in Sydney before working at the Liverpool and Rachel Foster Hospitals and in Papua New Guinea. Matthew completed his specialty training at the Prince Henry and Prince of Wales hospitals and was awarded his PhD and admitted as a Fellow of the Royal College of Australian Physicians with a specialisation in Neurology in 1997.

Matthew was awarded the fellowship to complete postdoctoral research in the Sobell Department of Neurophysiology at the Institute of Neurology in London and the Prince of Wales Medical Research Institute in Sydney. Upon completing the fellowship, Matthew hopes to continue his research through a career in academic neurology.

Studied at: Neuroscience Research Australia; Prince of Wales Hospital; Institute of Neurology; University College London

Current Biography

Professor Matthew Kiernan is the Brain and Mind Centre Co Director - Discovery and Translation. His role is to foster multidisciplinary research across the clinical neurosciences, to improve research outcomes and facilitate the translation of research innovations directly into clinical practice for the benefit of patients and the community

Professor Matthew Kiernan is the Bushell Chair of Neurology at the University of Sydney. His clinical research unit is located at the Brain and Mind Centre. He is a Professor of Neurology and Staff Specialist at the Royal Prince Alfred Hospital. He is also a Senior Scientist at Neuroscience Research Australia.

Professor Kiernan's leads a research group comprised of a team of clinicians, scientists, biomedical engineers, doctoraland postdoctoral students with focus on neurological disease. His research team's focus is clinical neurology, in particular disease pathophysiology and treatment strategies of frontotemporal dementia and motor neurone sydnromes. Currently his team is investigating the mechanisms and the possible prevention of neurodegeneration in motor neurone disease (MND) also known as amyotrophic lateral sclerosis (ALS); frontotemporal dementia; chemotherapy-induced neurotoxicity; stroke; Machado-Joseph disease; spinal muscular atrophy and other inherited neuropathies. He is also involved in clinical trials investigating potential drug treatments for motor neurone disease, multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. His team's research is intrinsically linked to the provision of clinical services, particularly the ForeFront Multidisciplinary Motor Neurone Disease & Fronto temporal Dementia Clinic and diagnostic neurophysiology clinics.

Professor Kiernan is the Editor-in-Chief of the Journal of Neurology, Neurosurgery and Psychiatry (BMJ Publishing Group). He is also the Director of the Motor Neurone Disease Research Institute of Australia and Vice President of the Australian Brain Foundation, the largest priming institution for neuroscience in Australia, responsible for distributing funding towards research and medical education for the treatment and prevention of neurological disorders.

Scholarship Year: 1999

Fields of Interest